Maximal levels of Slc2a4 mRNA—encoding facilitated glucose transporter 4 (GLUT4) —were found in BAT of groups receiving MET, either alone or in combination with BC, yet with high interindividual variability (Figure 4A). Here, SLC2A4 is linked to breast cancer.